Evidence map›Paper›PMID 32594376›Full record

ArticleJournal of racial and ethnic health disparities2021

Stress and Drug Use from Prepregnancy, During Pregnancy, to Postpartum.

Z Helen Wu, Rong Wu, Elizabeth Brownell, Cheryl Oncken, James Grady

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Z Helen WuDepartment of Psychiatry, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030, USA. zwu@uchc.edu.ORCID http://orcid.org/0000-0001-8968-9286
Rong WuCenter of Biostatistics, Connecticut Convergence Institute for Translation in Regenerative Engineer, University of Connecticut Health Center, Farmington, CT, 06030, USA.
Elizabeth BrownellConnecticut Human Milk Research Center, Division of Neonatology, Connecticut Children's Medical Center, Hartford, CT, 06106, USA.
Cheryl OnckenDepartment of Medicine, University of Connecticut Health Center, Farmington, CT, 06030, USA.
James GradyCenter of Biostatistics, Connecticut Convergence Institute for Translation in Regenerative Engineer, University of Connecticut Health Center, Farmington, CT, 06030, USA.
UConn Health · USConnecticut Children's Medical Center · US

Funding

Moving Alcoholism Treatment Behavioral Therapies from the Lab to the CommunityP30AA019358 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HESSELBROCK, VICTOR M · 2009 to 2010
$916k
Does Stress Influence Drug Use in Young, Poor Women?K01DA021814 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WU, Z HELEN · 2006 to 2009
$609k
NIAAA NIH HHS AA019358NIDA NIH HHS DA020053NIDA NIH HHS DA021814
6 · The paper itself

Abstract

objectiveTo document changes of stress and illicit drug use among women from 4 months prepregnancy to 6 months postpartum. STUDY

designIn a longitudinal study of drug use in family planning clinics, 121 women who became pregnant were matched with 202 women who did not become pregnant. Self-reported drug use, Cohen's Perceived Stress Scale, and open-ended stress questions were examined every 2 months during the study period of time.

resultsAmong drug-using pregnant women, drug use declined during 2nd and 3rd trimesters and increased immediately within 1 to 2 months postpartum. Levels of perceived stress declined throughout pregnancy up to 2 months postpartum, increased at 3 to 4 months postpartum and then declined at 6 months postpartum. In contrast, among nondrug-using pregnant women, stress remained stable until the 2nd trimester, increased from 3rd trimester to 1-2 months postpartum, then declined continuously to 6 months postpartum. For non-pregnant women, at the matched timeline, there was no clear pattern for changes of drug use and stress.

conclusionsOur study has illustrated a complex time course of changes of both perceived stress and drug use from prepregnancy through 6 months postpartum. For drug-using pregnant women, pregnancy showed protective effect in reduction of both drug use and stress during pregnancy; and during postpartum, drug resumption peaked at 1-2 months while stress peaked at 3-4 months. If we can identify modifiable, pregnancy-related resiliency factors for both stress and drug use, we can begin to extend prevention efforts initiated during pregnancy into the postpartum period.

Indexed as

AdolescentAdultFemaleHumansLongitudinal StudiesPeripartum PeriodPostpartum PeriodPregnancyPregnant PeopleStress, PsychologicalSubstance-Related DisordersYoung AdultDrug usePostpartumPregnancyPrepregnancyStress

Identifiers

PMID32594376
OpenAlexW3037860950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.